As observed with all CD4+ T cells, when computed with PD-1+ CD4+ T cells, tumor cells, and Tregs, the SpatialScore was lower in responders than nonresponders (Fig. 4c, compare mean SpatialScore for R, pre (0.40) versus NR, pre (0.62)). The gene discussed is PDCD1; the disease is neoplasm.